Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · IEX Real-Time Price · USD
2.835
+0.150 (5.59%)
At close: Apr 19, 2024, 4:00 PM
2.980
+0.145 (5.11%)
After-hours: Apr 19, 2024, 7:22 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $195.50 million as of April 19, 2024. Its market cap has increased by 76.93% in one year.
Market Cap
195.50M
Enterprise Value
113.87M
1-Year Change
76.93%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $140.20M to $195.50M, an increase of 39.45%. That is a compound annual growth rate of 6.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 195.50M | 5.56% |
Apr 18, 2024 | 185.20M | 4.10% |
Apr 17, 2024 | 177.90M | -3.21% |
Apr 16, 2024 | 183.80M | -5.16% |
Apr 15, 2024 | 193.80M | -3.77% |
Apr 12, 2024 | 201.40M | -2.00% |
Apr 11, 2024 | 205.50M | 9.13% |
Apr 10, 2024 | 188.30M | -5.19% |
Apr 9, 2024 | 198.60M | -8.14% |
Apr 8, 2024 | 216.20M | 2.13% |
Apr 5, 2024 | 211.70M | -1.12% |
Apr 4, 2024 | 214.10M | -1.74% |
Apr 3, 2024 | 217.90M | -2.16% |
Apr 2, 2024 | 222.70M | -3.88% |
Apr 1, 2024 | 231.70M | -2.61% |
Mar 28, 2024 | 237.90M | -0.59% |
Mar 27, 2024 | 239.30M | 2.35% |
Mar 26, 2024 | 233.80M | 1.21% |
Mar 25, 2024 | 231.00M | -6.70% |
Mar 22, 2024 | 247.60M | -2.98% |
Mar 21, 2024 | 255.20M | 4.55% |
Mar 20, 2024 | 244.10M | 10.50% |
Mar 19, 2024 | 220.90M | 6.46% |
Mar 18, 2024 | 207.50M | -2.99% |
Mar 15, 2024 | 213.90M | 7.00% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Akoya Biosciences | 187.23M |
Profound Medical | 186.88M |
Compass Therapeutics | 186.13M |
Alpha Tau Medical | 186.02M |
Innate Pharma | 186.02M |
908 Devices | 185.28M |
Generation Bio Co. | 184.81M |
Rigel Pharmaceuticals | 184.15M |